Related Experiment Video
Updated: May 23, 2026
08:18
Three-Dimensional Reconstruction of Orbital Fractures
Published on: May 16, 2025
Bisphosphonate-associated orbital inflammation--a case report and review
Jared D Peterson1, Edward H Bedrossian
1Oculoplastic and Orbital Surgery Service, Wills Eye Institute, Philadelphia, PA 19107, USA. jpete123456789@gmail.com
Orbit (Amsterdam, Netherlands)
|April 12, 2012
Summary
Bisphosphonates can cause serious orbital inflammation, a rare but significant ocular side effect. Prompt recognition and treatment are crucial, though future bisphosphonate use may still be possible.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Bisphosphonates are increasingly prescribed for various conditions.
- Ocular side effects of bisphosphonates are a growing concern.
- Orbital inflammation is a potentially serious adverse event associated with bisphosphonate use.
Observation:
- This report details an additional case of bisphosphonate-induced orbital inflammation.
- Common signs include eyelid edema, conjunctival hyperemia, and chemosis.
- Symptoms often involve pain, diplopia, and blurred vision.
Findings:
- Anterior uveitis occurs in 30% of cases.
- Bilateral involvement is observed in approximately 30% of cases.
- Two instances of profound visual loss underscore the severity of this condition.
Implications:
- Early diagnosis and management of bisphosphonate-related orbital inflammation are essential.
- Despite the risk, patients may not be precluded from future bisphosphonate therapy.
- Further research is needed to fully understand the long-term implications and management strategies.
Related Concept Videos
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...